Oncolytic herpes simplex virus and therapeutic uses thereof | Patent Publication Number 20200113956
US 20200113956 A1Patent NumberUS 11147846 B2
Application Number16578178
Filled DateSep 20, 2019
Priority DateSep 8, 2011
Publication DateApr 16, 2020
Original AssigneeNew York University
Johnson & Johnson
Johnson & Johnson
Current AssigneeJanssen Biotech Inc.
New York University
New York University
Inventor/ApplicantsIan J. Mohr
Matthew Mulvey
Matthew Mulvey
![Patent Prosecution report image](/_next/image?url=https%3A%2F%2Fpatexia-data.s3.amazonaws.com%2Fconnect%2F65256ba2e3fa03282001bdac%2F280_c4899fec3f1140f6f1ec05c01211cc01.jpg&w=384&q=75)
Empower your practice with Patexia Publication Prosecution IP Module.
Get access to our exclusive rankings and unlock powerful data.
Looking for a Publication Attorney?
Get in touch with our team or create your account to start exploring a
network of over 120K attorneys.